Medicines safety
General information about the safety of medicines and how it is monitored. This includes various kinds of reviews of specific medicines guidelines and monitoring by the TGA.
Latest alerts
-
The oral antihistamine promethazine hydrochloride, sold as Phenergan and other generic brands, should not be given to children under 6 years of age.
-
We have tested a further 6 imported, unregistered ivermectin products and found they are counterfeit under the Therapeutic Goods Act 1989.
-
African Vigorous Max Strength poses a serious risk to your health and should not be taken.
Latest articles
-
Product Information safety updates - November 2024
Information for health professionals about medicines with safety related updates to their Product Information. -
Promethazine hydrochloride (Phenergan) not to be used in children under 6
Health professionals and consumers are advised that the oral antihistamine promethazine hydrochloride, sold as Phenergan and other generic brands, should not be used in children under 6 years of age. -
Shingrix vaccine and very rare risk of Guillain-Barré Syndrome
We have received Australian reports of Guillain-Barré Syndrome (GBS) following Shingrix vaccination.
Latest publications
-
Advisory Committee on Medicines meeting statement
-
Advisory Committee on Medicines meeting statement
-
This web publication constitutes a notice for the purposes of regulations 42ZCZS and 42ZCZX of the Therapeutic Goods Regulations 1990 (the Regulations).